As of the first quarter of 2026, the average sales price (ASP) of autoimmune disease drug Remicade was 293 U.S. dollars, compared to 245 U.S. dollars for biosimilar Renflexis. Biosimilars significantly reduce the price.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Samsung Bioepis. (April 27, 2026). Comparison of the average sales price (ASP) of Remicade vs biosimilars in the United States as of first quarter of 2026 (in U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 19, 2026, from /statistics/1186626/comparison-asp-remicade-vs-biosimilars-us/
Samsung Bioepis. "Comparison of the average sales price (ASP) of Remicade vs biosimilars in the United States as of first quarter of 2026 (in U.S. dollars)." Chart. April 27, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 19, 2026. /statistics/1186626/comparison-asp-remicade-vs-biosimilars-us/
Samsung Bioepis. (2026). Comparison of the average sales price (ASP) of Remicade vs biosimilars in the United States as of first quarter of 2026 (in U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 19, 2026. /statistics/1186626/comparison-asp-remicade-vs-biosimilars-us/
Samsung Bioepis. "Comparison of The Average Sales Price (Asp) of Remicade Vs Biosimilars in The United States as of First Quarter of 2026 (in U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 27 Apr 2026, /statistics/1186626/comparison-asp-remicade-vs-biosimilars-us/
Samsung Bioepis, Comparison of the average sales price (ASP) of Remicade vs biosimilars in the United States as of first quarter of 2026 (in U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1186626/comparison-asp-remicade-vs-biosimilars-us/ (last visited July 19, 2026)
Comparison of the average sales price (ASP) of Remicade vs biosimilars in the United States as of first quarter of 2026 (in U.S. dollars) [Graph], Samsung Bioepis, April 27, 2026. [Online]. Available: /statistics/1186626/comparison-asp-remicade-vs-biosimilars-us/
